- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to evaluate the safety of ReFacto AF in previously untreated patients less than 6 years of age.
Inclusion criteria
- Severe hemophilia A (FVIII:C <1%) in male subjects <6 years of age. Hemofilia A severa (FVIII:C<1%) en sujetos pediátricos menores de seis años de edad